Cite
HARVARD Citation
Nakata, J. et al. (2019). What should we tackle next in acute myeloid leukemia? Wilms tumor gene 1 vaccine therapy would be a promising and versatile strategy for acute myeloid leukemia. Expert review of hematology. 12 (4), pp. 211-213. [Online].